Research is rapidly identifying the compounds from plants that are most effective against cancer. Among those that are proving to be the front line of defense against an initial diagnosis of cancer and to prevent recurrence are DIM, curcumin, EGCG, genistein, and I3C. Each has its own unique actions, and when taken together in small amounts they are much more powerful than taking a large amount of only one or two. Each is readily available in supplement form. Read the rest of this entry »

Two Chinese dietary staples – mushrooms and green tea – may have the power to ward off breast cancer, mounting evidence suggests. A study of over 2,000 Chinese women in the International Journal of Cancer found large quantities of both in the diet slashed cancer risk by up to 90%. Read the rest of this entry »
October is officially tagged “Breast Cancer Awareness Month”. Of recent, there have been a lot of medical breakthroughs in the detection and treatment of Breast Cancer. Scientists have identified more accurate tools for screening younger women who are more likely to get the most dangerous forms and new strategies have also been developed for the treatment of newly diagnosed pregnant women. Advanced research has led to the development of better, less toxic drugs to guard against recurrences. Read the rest of this entry »

“This novel proteasome inhibitor appears to improve response rates and
survival in patients with progressive multiple myeloma.” Read the rest of this entry »
It takes a uniquely gifted performer to make cancer treatment seem funny.Jenny Allen achieves that feat in her personal and witty solo monologue, “I Got Sick Then I Got Better,” now in an extended run at the New York Theatre Workshop’s 4th Street Theatre. Read the rest of this entry »

Iressa (gefitinib) Improves Progression-free Survival over Standard Chemotherapy in Patients with NSCLC with EGFR Mutations. Read the rest of this entry »
Hélio de Carvalho knows all too well that breast cancer isn’t only a women’s illness.The Brazilian immigrant, 52, not only lived with the disease, but survived due to early detection.”I found it during a game with my ex-wife. I made her do self-exams and she told me I would have to do it too. That’s precisely when we noticed a lump on me. I thought it was nothing, but the doctor detected cancer,” Carvalho said. Read the rest of this entry »

UK’s drug watchdog National Institute for Clinical Excellence (NICE) has advised against public funding of Tyverb® (lapatinib) on grounds of cost. The drug is a treatment for an aggressive form of advanced breast cancer (ErbB2-positive). Drug makers GSK say they are considering an appeal against the decision. Read the rest of this entry »

Breast cancer is a topic that seldom evokes dispassionate, let alone objective, treatment. There is good reason for that. We all know, often intimately, of the tragedy this cancer can cause. Read the rest of this entry »
A quiet coup is taking place in American medicine cabinets. Prescription bottles bearing catchy brand names like Zoloft and Flonase are being pushed aside by tongue-twisting generics like sertraline and fluticasone propionate. While the trend is already pinching the profits of big pharmaceutical companies, it is rare good medical news for American pocketbooks. Read the rest of this entry »
Most Commented